Distribution of amyloid precursor protein and amyloid-β in ocular hypertensive C57BL/6 mouse eyes

Current Eye Research

Volumn 35, Issue 9, 2010, Pages 828-834

  Kipfer Kauer, Anna ^a,b   McKinnon, Stuart J ^c   Frueh, Beatrice E ^a   Goldblum, David ^d  

^a UNIVERSITY OF BERN   (Switzerland)

^b Kantonsspital Luzern ^*  (Switzerland)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer; Amyloid; Amyloid precursor protein; Glaucoma; Optic nerve

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; PARAFORMALDEHYDE; POLYCLONAL ANTIBODY; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; C57BL 6 MOUSE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DURA MATER; GLAUCOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MOUSE; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; RETINA GANGLION CELL; WILD TYPE;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; DURA MATER; IMMUNOENZYME TECHNIQUES; INTRAOCULAR PRESSURE; MICE; MICE, INBRED C57BL; OCULAR HYPERTENSION; OPTIC NERVE; PIA MATER; RETINA; RETINAL GANGLION CELLS; TONOMETRY, OCULAR;

EID: 77956154003     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.494240     Document Type: Article

References (27)

1. McKinnon SJ, Lehman DM, Kerrigan-Baumrind LA, et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci. 2002; 43:1077-1087.
2. Moya KL, Benowitz LI, Schneider GE, et al. The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev Biol. 1994;16:597-603.
3. Masliah E. Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol. 1995;10:509-519.
4. Morin PJ, Abraham CR, Amaratunga A, et al. Amyloid precursor protein is synthesized by retinal ganglion cells, rapidly transported to the optic nerve plasma membrane and nerve terminals, and metabolized. J Neurochem. 1993;6:464-473.
5. Bayer AU, Ferrari F, Erb C. High occurrence rate of glaucoma among patients with Alzheimer's disease. Eur Neurol. 2002;47:165-168.
6. Wostyn P, Audenaert K, De Deyn P P. Alzheimer's disease-related changes in diseases characterized by elevation of intrac-ranial or intraocular pressure. J Neurochem. 1993;61:464-473.
7. Goldblum D, Kipfer-Kauer A, Sarra GM, et al. Distribution of amyloid precursor protein and amyloid-beta immuno-reactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci. 2007;48:5085-5090.
8. McKinnon SJ, Reitsamer HA, Ransom NL, et al. Induction and tonopen measurement of ocular hypertension in C57BL/6 mice. Invest Ophthalmol Vis Sci. 2003;44:e-abstract 3319.
9. Morrison JC, Moore CG, Deppmeier LM, et al. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
10. Sturchler-Pierrat C, Abramowski D, Duke M, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci\USA. 1997;94:13287-13292.
11. Schrader-Fischer G, Paganetti PA. Effect of alkalizing agents on the processing of the beta-amyloid precursor protein. Brain Res. 1996;716:91-100.
12. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science. 2006;313:1781-1784.
13. Janciauskiene S, Krakau T. Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome. Doc Ophthalmol. 2003;106:215-223.
14. Walsh MM, Yi H, Friedman J, et al. Gene and protein expression pilot profling and biomarkers in an experimental mouse model of hypertensive glaucoma. Exp Biol Med. 2009;234:918-930.
15. McKinnon SJ. Glaucoma: Ocular Alzheimer's disease Front Biosci. 2003;8:1140-1156.
16. Martin KR, Quigley HA, Valenta D, et al. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp Eye Res. 2006;83:255-262.
17. Kamal A, Almenar-Queralt A, LeBlanc JF, et al. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001;414:643-648.
18. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science. 1990;250:279-282.
19. Guo L, Salt TE, Luong V, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci\USA. 2007;104:13444-13449.
20. Santiago-García J, Mas-Oliva J, Innerarity TL, et al. Secreted forms of the amyloid-beta precursor protein are ligands for the class A scavenger receptor. J Biol Chem. 2001;276:30655-30661.
21. Joachim CL, Duffy LK, Morris JH, et al. Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging. Brain Res. 1988;474:100-111.
22. Kim DH, Kim HS, Ahn MD, et al. Ganglion cell death in rat retina by persistent intraocular pressure elevation. Korean J Ophthalmol. 2004;18:15-22.
23. Guo L, Moss SE, Alexander RA, et al. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthal-mol Vis Sci. 2005;46:175-182.
24. Dovey HF, John V, Anderson JP, et al. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem. 2001;76:173-181.
25. McKinnon SJ, Lehman DM, Tahzib NG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther. 2002;5:780-787.
26. Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6:916-919.
27. Wilcock DM, Jantzen PT, Li Q, et al. Amyloid-beta vaccination, but not nitro-nonsteroidal anti-infammatory drug treatment, increases vascular amyloid and microhemor-rhage while both reduce parenchymal amyloid. Neurosci-ence. 2007;144:950-960.